A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2011
10/06/2011	US20110245222 Methods for Using Carboxamide, Sulfonamide and Amine Compounds
10/06/2011	US20110245220 Compounds and compositions as modulators of gpr119 activity
10/06/2011	US20110245216 Use of dhea derivatives for enhancing physical performance
10/06/2011	US20110245209 Pyridopyrimidine derivatives and methods of use thereof
10/06/2011	US20110245207 Method for moderately increasing the proton conductivity of biological membranes with the aid of mitochondria-targeted delocalized cations
10/06/2011	US20110245204 Cycloalkane-containing sphingosine 1-phosphate agonists
10/06/2011	US20110245196 Novel sulfated oligosaccharide derivatives
10/06/2011	US20110245178 Exendin Fusion Proteins
10/06/2011	US20110245174 Glp-1 fusion polypeptides
10/06/2011	US20110245166 Sugar chain added glp-1 peptide
10/06/2011	US20110245165 Peptide agonists of glp-1 activity
10/06/2011	US20110245164 Yl-based insulin-like growth factors exhibiting high activity at the insulin receptor
10/06/2011	US20110245163 Stabilised Insulin Compositions
10/06/2011	US20110245162 Methods for treating diabetes and reducing body weight
10/06/2011	US20110245161 Use of Ghrelin Splice Variant for Treating Hypercholesterolemia and/or High Cholesterol and/or High Cholesterol Complication and/or Lipemia and/or Lipemia Complication and/or Coronary Heart Disease and/or Weight Management and/or Diabetes and/or Hyperglycemia
10/06/2011	US20110245160 Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity
10/06/2011	US20110245159 Salts, Solvates and Pharmaceutical Compositions of Macrocyclic Ghrelin Receptor Agonists and Methods of Using the Same
10/06/2011	US20110245158 High Protein Supplement
10/06/2011	US20110245146 Non-Viral Delivery of Compounds to Mitochondria
10/06/2011	US20110245145 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance
10/06/2011	US20110244061 Formulations and Methods for Increasing Metabolic Rate and Weight Control
10/06/2011	US20110244060 Cardioprotective effects of nutraceuticals isolated from nigella sativa seeds
10/06/2011	US20110244059 Inhibiting obesity progression by inhibiting adipocyte differentiation with a pre-adipocyte autophagy inhibitor
10/06/2011	US20110244055 Compositions and methods for promoting appetite suppression using alkali metals
10/06/2011	US20110244019 Absorbent fabric implant
10/06/2011	US20110244002 Mesoporous material excipients for poorly aqueous soluble ingredients
10/06/2011	US20110243984 composition for treatment of diabetes mellitus and a preparation and an use thereof
10/06/2011	US20110243962 Therapeutic use of specific ligand in msrv associated diseases
10/06/2011	US20110243953 Neutralizing antibodies against gdf-8 and uses therefor
10/06/2011	US20110243948 Monoclonal Antibodies Against ANGPTL3
10/06/2011	US20110243940 Bicyclic pyranone derivatives and methods of use thereof
10/06/2011	US20110243938 Methods to Reduce B-Helper T Cells to Treat Autoimmune Diseases
10/06/2011	US20110243936 TNFalpha-NEUTRALIZING ANTIBODIES
10/06/2011	US20110243932 Anti-cd40 antibodies
10/06/2011	US20110243930 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110243923 Organic compounds
10/06/2011	US20110243922 Genetic Alterations Associated with Type I Diabetes and Methods of Use Thereof for Diagnosis and Treatment
10/06/2011	US20110243910 mammalian rna dependent rna polymerase
10/06/2011	US20110243902 Method for treating or preventing a pancreatic dysfunction
10/06/2011	US20110243901 Compositions and Methods for the Treatment of Lysosomal Storage Disorders
10/06/2011	US20110243885 Use of Genomic Testing and Ketogenic Compounds for Treatment of Reduced Cognitive Function
10/06/2011	US20110243881 Biocompatible polymers, process for their preparation and compositions containing them
10/06/2011	US20110243845 Somatostatin analogs with inhibitory activity to growth hormone release
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	CA2796567A1 Composition comprising insulin and herbal oil for transdermal or transmucosal administration
10/06/2011	CA2795009A1 Aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists
10/06/2011	CA2794734A1 Transdermal delivery patch
10/06/2011	CA2793777A1 Formulations of mazindol
10/05/2011	EP2371861A1 Monoclonal antibodies against extracellular loops of C5aR
10/05/2011	EP2371826A1 Novel fused ring compound and use thereof
10/05/2011	EP2371379A2 New formulation for increasing bioavailability of neurturin
10/05/2011	EP2371376A1 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance
10/05/2011	EP2371372A1 Methods of promoting appetite suppression using alkali metals
10/05/2011	EP2371366A1 Heterocyclo inhibitors of potassium channel function
10/05/2011	EP2370472A1 Leptin and leptin analog conjugates and uses thereof
10/05/2011	EP2370440A1 Novel compounds
10/05/2011	EP2370434A1 Corydaline derivatives useful for reducing lipid levels
10/05/2011	EP2370427A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and uses thereof
10/05/2011	EP2370426A1 N-{[(ir,4s,6r-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-yl]methyl}-2-heteroarylamine derivatives and uses thereof
10/05/2011	EP2370061A2 Pharmaceutical composition comprising ezetimibe and simvastatin
10/05/2011	EP2369945A2 Companion animal compositions including lipoic acid and methods of use thereof
10/05/2011	EP2369944A1 Protein particles and their use in food
10/05/2011	EP1656139B1 Aryl dicarboxamides
10/05/2011	EP1648874B1 Piperazine derivatives and their use as therapeutic agents
10/05/2011	EP1501830B1 7-aryl-3,9-diazabicyclo[3.3.1]non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
10/05/2011	EP1463497B1 Treating muscle wasting with selective androgen receptor modulators
10/05/2011	EP1377276B1 Timed pulse release composition
10/05/2011	EP1355676B1 Method of protecting therapeutic compositions from host-mediated inactivation
10/05/2011	CN1896069B Substituted-thiazole-4-ketone, its preparation and use
10/05/2011	CN1806796B Pharmaceutical composition containing valibose, its preparation method and application
10/05/2011	CN1446227B Novel fibroblast growth factor (FRF23) and method for use
10/05/2011	CN102206677A Construction and application of overexpression vector of mouse adiponectin gene
10/05/2011	CN102206291A Process for extracting yam polysaccharide by using supercritical CO2 fluid extraction technique
10/05/2011	CN102206289A Extraction process for polysaccharide from Bassia rapa L.
10/05/2011	CN102206277A Antibodies that bind human interleukin-18 and methods of making and using
10/05/2011	CN102206243A Medical application of ursolic acid-NF (Nuclear Factor)-kappaB inhibitor
10/05/2011	CN102206217A Heterocyclic compounds for treating or preventing diabetes mellitus as dipeptidyl peptidase inhibitor
10/05/2011	CN102206139A Kaurane compound, and preparation method and purpose thereof
10/05/2011	CN102205095A Medicinal composition with auxiliary blood sugar reducing effect
10/05/2011	CN102205088A Chinese medicinal capsules for treating fatty liver
10/05/2011	CN102205066A Traditional Chinese medicine (TCM) for treating diabetes
10/05/2011	CN102205046A Medicament for reducing blood fat
10/05/2011	CN102205041A Chinese patent medicine and Chinese decoction capable of effectively treating diabetes
10/05/2011	CN102205011A Medicinal composition with weight loss function
10/05/2011	CN102205010A Pharmaceutical composition with auxiliary function of reducing blood fat
10/05/2011	CN102205005A Chinese medicinal preparation for treating diabetic nephropathy
10/05/2011	CN102204997A Scindapsus aureus extract for treating diabetic nephropathy and preparation method and application thereof
10/05/2011	CN102204990A Couplet medicine extract for reducing sugar content and preventing diabetic angiopathy and preparation method thereof
10/05/2011	CN102204985A Compound lychee seed hpyerglycemic particles and preparation method thereof
10/05/2011	CN102204976A Pummelo peel extract with hypoglycemic activity and preparation method thereof
10/05/2011	CN102204964A Composite natural medicament used for preventing and treating metabolic syndrome and preparation method and medicinal application thereof
10/05/2011	CN102204952A Perilla extract buccal tablet
10/05/2011	CN102204951A Method for extracting active components from licorice
10/05/2011	CN102204942A Method for extracting corylus heterophylla leaf flavone
10/05/2011	CN102204940A Evening primrose oil microcapsule and pulverization method
10/05/2011	CN102204939A Method for preparing pomegranate peel polyphenol liposome by reverse evaporation method
10/05/2011	CN102204918A Steroid compound agonist for PPARgamma and its purpose
10/05/2011	CN102204894A Iodized lecithin enteric capsule preparation and preparation method thereof
10/05/2011	CN102204871A Composition for weight loss
10/05/2011	CN102204867A Preparation method of liposome with functions of fat reduction and calcium supplement

1 ... 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 ... 1298